Ropivacaine is an aminoamide local anesthetic drug marketed by AstraZeneca under the trade name Naropin. It exists as a racemate of its S- and R-enantiomers, although the marketed form is supplied only as the purified S-enantiomer.
Ropivacaine is indicated in adult patients for the induction of regional or local anesthesia for surgery or acute pain management.
Healthpoint Hospital, Abu Dhabi, United Arab Emirates
Healthpoint Hospital, Abu Dhabi, United Arab Emirates
Central Hospital in Karlstad, Karlstad, Värmland, Sweden
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States
Complejo Asistencial Universitario de Salamanca, Salamanca, Spain
Bispebjerg Hospital, Copenhagen, Denmark
Shengjing Hospital, Shengyang, Liaoning, China
National Center for Oncology, Astana, Kazakhstan
Ochsner Medical Center, Jefferson, Louisiana, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.